These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 9477096)

  • 1. Determination of pancreatic ductal carcinoma histogenesis by analysis of mucous quality and K-ras mutation.
    Matsubayashi H; Watanabe H; Nishikura K; Ajioka Y; Kijima H; Saito T
    Cancer; 1998 Feb; 82(4):651-60. PubMed ID: 9477096
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Multiple K-ras mutations in hyperplasia and carcinoma in cases of human pancreatic carcinoma.
    Matsubayashi H; Watanabe H; Yamaguchi T; Ajioka Y; Nishikura K; Iwafuchi M; Yamano M; Kijima H; Saito T
    Jpn J Cancer Res; 1999 Aug; 90(8):841-8. PubMed ID: 10543256
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Different amounts of K-ras mutant epithelial cells in pancreatic carcinoma and mass-forming pancreatitis.
    Matsubayashi H; Watanabe H; Ajioka Y; Nishikura K; Yamano M; Seki T; Saito T; Matsubayashi T
    Pancreas; 2000 Jul; 21(1):77-85. PubMed ID: 10881936
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Detection of K-ras mutations in mucinous pancreatic duct hyperplasia from a patient with a family history of pancreatic carcinoma.
    DiGiuseppe JA; Hruban RH; Offerhaus GJ; Clement MJ; van den Berg FM; Cameron JL; van Mansfeld AD
    Am J Pathol; 1994 May; 144(5):889-95. PubMed ID: 8178941
    [TBL] [Abstract][Full Text] [Related]  

  • 5. High yields of K-ras mutations in intraductal papillary mucinous tumors and invasive adenocarcinomas induced by N-nitroso(2-hydroxypropyl)(2-oxopropyl)amine in the pancreas of female Syrian hamsters.
    Sugio K; Gazdar AF; Albores-Saavedra J; Kokkinakis DM
    Carcinogenesis; 1996 Feb; 17(2):303-9. PubMed ID: 8625455
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The role of p21ras in pancreatic neoplasia and chronic pancreatitis.
    Mulligan NJ; Yang S; Andry C; Klein M; O'Brien MJ
    Hum Pathol; 1999 Jun; 30(6):602-10. PubMed ID: 10374765
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mutational activation of K-ras in nonneoplastic exocrine pancreatic lesions in relation to cigarette smoking status.
    Berger DH; Chang H; Wood M; Huang L; Heath CW; Lehman T; Ruggeri BA
    Cancer; 1999 Jan; 85(2):326-32. PubMed ID: 10023699
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The K-ras mutation pattern in pancreatic ductal adenocarcinoma usually is identical to that in associated normal, hyperplastic, and metaplastic ductal epithelium.
    Lüttges J; Schlehe B; Menke MA; Vogel I; Henne-Bruns D; Klöppel G
    Cancer; 1999 Apr; 85(8):1703-10. PubMed ID: 10223563
    [TBL] [Abstract][Full Text] [Related]  

  • 9. K-ras mutations in the duodenal fluid of patients with pancreatic carcinoma.
    Wilentz RE; Chung CH; Sturm PD; Musler A; Sohn TA; Offerhaus GJ; Yeo CJ; Hruban RH; Slebos RJ
    Cancer; 1998 Jan; 82(1):96-103. PubMed ID: 9428484
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clonality and field cancerization in intraductal papillary-mucinous tumors of the pancreas.
    Izawa T; Obara T; Tanno S; Mizukami Y; Yanagawa N; Kohgo Y
    Cancer; 2001 Oct; 92(7):1807-17. PubMed ID: 11745253
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prevalence of activating K-ras mutations in the evolutionary stages of neoplasia in intraductal papillary mucinous tumors of the pancreas.
    Z'graggen K; Rivera JA; Compton CC; Pins M; Werner J; Fernández-del Castillo C; Rattner DW; Lewandrowski KB; Rustgi AK; Warshaw AL
    Ann Surg; 1997 Oct; 226(4):491-8; discussion 498-500. PubMed ID: 9351717
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A two-step enriched-nested PCR technique enhances sensitivity for detection of codon 12 K-ras mutations in pancreatic adenocarcinoma.
    Banerjee SK; Makdisi WF; Weston AP; Campbell DR
    Pancreas; 1997 Jul; 15(1):16-24. PubMed ID: 9211488
    [TBL] [Abstract][Full Text] [Related]  

  • 13. K-ras mutations and allelic loss at 5q and 18q in the development of human pancreatic cancers.
    Sugio K; Molberg K; Albores-Saavedra J; Virmani AK; Kishimoto Y; Gazdar AF
    Int J Pancreatol; 1997 Jun; 21(3):205-17. PubMed ID: 9322119
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pancreatic carcinomas of acinar and mixed acinar/ductal phenotypes in Ela-1-myc transgenic mice do not contain c-K-ras mutations.
    Schaeffer BK; Terhune PG; Longnecker DS
    Am J Pathol; 1994 Sep; 145(3):696-701. PubMed ID: 8080049
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Duct changes and K-ras mutations in the disease-free pancreas: analysis of type, age relation and spatial distribution.
    Lüttges J; Reinecke-Lüthge A; Möllmann B; Menke MA; Clemens A; Klimpfinger M; Sipos B; Klöppel G
    Virchows Arch; 1999 Nov; 435(5):461-8. PubMed ID: 10592048
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Detection of K-ras mutations in the stool of patients with pancreatic adenocarcinoma and pancreatic ductal hyperplasia.
    Caldas C; Hahn SA; Hruban RH; Redston MS; Yeo CJ; Kern SE
    Cancer Res; 1994 Jul; 54(13):3568-73. PubMed ID: 8012983
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ductal lesions in patients with chronic pancreatitis show K-ras mutations in a frequency similar to that in the normal pancreas and lack nuclear immunoreactivity for p53.
    Lüttges J; Diederichs A; Menke MA; Vogel I; Kremer B; Klöppel G
    Cancer; 2000 Jun; 88(11):2495-504. PubMed ID: 10861425
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Molecular pathology of primary and metastatic ductal pancreatic lesions: analyses of mutations and expression of the p53, mdm-2, and p21/WAF-1 genes in sporadic and familial lesions.
    Ruggeri BA; Huang L; Berger D; Chang H; Klein-Szanto AJ; Goodrow T; Wood M; Obara T; Heath CW; Lynch H
    Cancer; 1997 Feb; 79(4):700-16. PubMed ID: 9024708
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Foamy gland pattern of pancreatic ductal adenocarcinoma: a deceptively benign-appearing variant.
    Adsay V; Logani S; Sarkar F; Crissman J; Vaitkevicius V
    Am J Surg Pathol; 2000 Apr; 24(4):493-504. PubMed ID: 10757396
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sequential accumulation of K-ras mutations and p53 overexpression in the progression of pancreatic mucinous cystic neoplasms to malignancy.
    Jimenez RE; Warshaw AL; Z'graggen K; Hartwig W; Taylor DZ; Compton CC; Fernández-del Castillo C
    Ann Surg; 1999 Oct; 230(4):501-9; discussion 509-11. PubMed ID: 10522720
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.